Emideltide narrowly voted down by FDA peptide advisory panel on Day 2 on July 24, 2026 Advisory Committees compounding pharmacies Delta Sleep-Inducing Peptide Emideltide Opioids PCAC Peptides sleep-inducing peptide Sleeplessness United States Food and Drug Administration Withdraw (activity) +